Approvals/TGA/NOVISTIG glycopyrronium bromide (glycopyrrolate)/neostigmine methylsulfate 0.5 mg/2.5 mg per 1 mL injection solution ampoule

Approved

STANDARD

NOVISTIG glycopyrronium bromide (glycopyrrolate)/neostigmine methylsulfate 0.5 mg/2.5 mg per 1 mL injection solution ampoule

Boucher & Muir Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 14b968c8e67f7d3e
Product Name: NOVISTIG glycopyrronium bromide (glycopyrrolate)/neostigmine methylsulfate 0.5 mg/2.5 mg per 1 mL injection solution ampoule
Artg Id: 303637
Artg Name: NOVISTIG glycopyrronium bromide (glycopyrrolate)/neostigmine methylsulfate 0.5 mg/2.5 mg per 1 mL injection solution ampoule
Sponsor: Boucher & Muir Pty Ltd
Company Detail Path: /organization/boucher-and-muir-pty-ltd
Artg Date: 2019-08-20
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/aa12af1e4cf9698faf57fea468f637db.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/c3f90d116fde83f37e178b35d33c451c.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

14b968c8e67f7d3e

Type

Standard